The fixation system is used for conditions including degenerative sacroiliitis and sacroiliac joint disruption. It has a 3D-printed screw that’s offered in three diameters. The system has ChoiceSpine’s proprietary BioBond technology.
“The addition of the Triton screw to our spinal fusion portfolio delivers on ChoiceSpine’s commitment to provide an innovative, superior system to the sacroiliac fixation market,” Keith Clements, vice president of sales, said in a news release.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.